NASDAQ:GPCR | Free Cash Flow | Structure Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$15.23M$1.18M$14.05M
2025-12-31-$64.42M$1.5M-$65.91M-199.71%
2025-03-31-$52.23M$314,000.00-$52.54M
2024-12-31-$36.47M$16,000.00-$36.48M
2024-03-31-$34.08M$162,000.00-$34.24M
2023-12-31-$21.73M$1.16M-$22.89M
2023-03-31-$20.31M
2022-12-31-$12.03M$71,000.00-$12.1M
2022-03-31-$13.52M$65,000.00-$13.58M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$222.2M$3.61M-$225.81M
2024-12-31-$116.64M$1.29M-$117.93M
2023-12-31-$79.49M$2.17M-$81.66M
2022-12-31-$46.12M$155,000.00-$46.28M